Metraipolis › archive › dc_ea7a5b1e6df3

Factors Influencing the Use of G-CSF in Drug-Induced Agranulocytosis — Europe PMC PMID:41718416

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41718416
DOI
10.3390/hematolrep18010014
License (as archived)
solo-consultazione
Archived
2026-11-06T03:50:30.664Z
SHA-256 of the archived text
8915fb69a21303b2fbf72d9722b7f67e061fab86762153af56086084a00143c1
Stable URL of this page
https://metraipolis.com/documento/dc_ea7a5b1e6df3

How to cite

Factors Influencing the Use of G-CSF in Drug-Induced Agranulocytosis — Europe PMC PMID:41718416 — Europe PMC (en), https://europepmc.org/article/MED/41718416 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea7a5b1e6df3 (Metraipolis archive dc_ea7a5b1e6df3, sha256 8915fb69a21303b2fbf72d9722b7f67e061fab86762153af56086084a00143c1)
BibTeX
@misc{dcea7a5b1e6df3,
  title = {Factors Influencing the Use of G-CSF in Drug-Induced Agranulocytosis — Europe PMC PMID:41718416},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41718416},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea7a5b1e6df3; sha256 8915fb69a21303b2fbf72d9722b7f67e061fab86762153af56086084a00143c1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41718416. Agents can read the archived copy with the MCP tool read_document.